Resumo
Definition
History and exam
Key diagnostic factors
- widespread pain
- sleep disturbance/fatigue
- cognitive difficulties
Other diagnostic factors
- allodynia and/or hyperalgesia
- diffuse tenderness on exam
- sensitivity to sensory stimuli
- headaches
- abdominal pain
- mood disturbance
- numbness/tingling sensations
Risk factors
- family history of fibromyalgia
- rheumatologic conditions
- age between 20 and 60 years
- female sex
- stressful events
- sleep problems
- infections
- vitamin D deficiency
Diagnostic tests
1st tests to order
- clinical diagnosis
Tests to consider
- erythrocyte sedimentation rate (ESR)/CRP
- thyroid function test
- CBC
- blood chemistries
- LFTs
- rheumatoid factor
- anti-cyclic citrullinated protein (CCP) antibody
- antinuclear antibody or anti-DNA antibody
- vitamin D level
- creatinine kinase
- ferritin
- overnight oximetry/polysomnography
Treatment algorithm
mild or moderate fibromyalgia
severe fibromyalgia
Contributors
Authors
Matthew A. Bartlett, MB, BCh, BAO
Assistant Professor of Medicine
Fibromyalgia Clinic
Division of General Internal Medicine
Department of Internal Medicine
Mayo Clinic
Rochester, MN
Disclosures
MAB declares that he acts in an advisory role on the Medical Council for Kōkūn, a nonprofit organization that addresses conditions including fibromyalgia. He also owned stocks in Johnson & Johnson up to December 2025. No products developed or marketed by Johnson & Johnson are included in this topic.
Christopher V. Anstine, MD
Assistant Professor of Medicine
Fibromyalgia Clinic
Division of General Internal Medicine
Department of Internal Medicine
Mayo Clinic
Rochester, MN
Disclosures
CVA declares he has no competing interests.
Acknowledgements
Dr Matthew A. Barlett and Dr Christopher V. Anstine would like to gratefully acknowledge Dr Daniel J. Clauw and Dr Lisa Ware Corbin, previous contributors to this topic.
Disclosures
LWC and DJC declare that they have no competing interests.
Peer reviewers
Neel Mehta, MD
Division Chief
Pain Management
Weill Cornell Medicine
New York, NY
Disclosures
MD declares that they have no competing interests.
Don Goldenberg, MD
Emeritus Professor of Medicine
Tufts University School of Medicine
Boston, MA
Disclosures
DG declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-29. Abstract
Winslow BT, Vandal C, Dang L. Fibromyalgia: diagnosis and management. Am Fam Physician. 2023 Feb;107(2):137-44.Full text Abstract
Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-28.Full text Abstract
Kundakci B, Hall M, Atzeni F, et al. International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia. Semin Arthritis Rheum. 2022 Dec;57:152101.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Rheumatoid arthritis (RA)
- Polymyalgia rheumatica (PMR)
- Systemic lupus erythematosus (SLE)
More DifferentialsGuidelines
- Fibromyalgia: diagnosis and management
- 2016 revisions to the 2010/2011 American College of Rheumatology fibromyalgia diagnostic criteria
More GuidelinesPatient information
Fibromyalgia: what is it?
Fibromyalgia: what are the treatment options?
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer